PodParley PodParley
PodParley
Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg - report from EASD2022 episode artwork

EPISODE · Oct 11, 2022 · 7 MIN

Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg - report from EASD2022

from Medical Digest & Congress Report · host Medical Congress News

Domenica Rubino, Director of Washington Center for Weight Management & Research at Arlington, Virginia, USA, held a very interesting lecture about weight control at the recent EASD 2022 Congress. Video: https://congressreport.eu/scientific-contents/interview:semaglutide-24-mg-improved-glucose-metabolism-and-reverted-prediabetes-normoglycaemia-adults-overweight-or-obesity-vs-liraglutide-30-mg

Episode metadata supplied by the publisher feed · Published Oct 11, 2022

Embed this episode

Ready to play

Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg - report from EASD2022

0:00 7:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 7 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on October 11, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!